Hans-Peter Hartung
Affiliations: | Department of Neurology | Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Nordrhein-Westfalen, Germany |
Google:
"Hans-Peter Hartung"Mean distance: 106866
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bril V, Hartung HP, Lawo JP, et al. (2020) Electrophysiological testing in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin: The Polyneuropathy And Treatment with Hizentra (PATH) study. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology |
| Breitkopf K, Aytulun A, Förster M, et al. (2020) Case Report: A Case of Severe Clinical Deterioration in a Patient With Multiple Sclerosis. Frontiers in Neurology. 11: 782 |
| Graf J, Albrecht P, Goebels N, et al. (2020) [Erratum to: Ocrelizumab for treatment of multiple sclerosis]. Der Nervenarzt |
| Sorensen PS, Sellebjerg F, Hartung HP, et al. (2020) The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history. Brain : a Journal of Neurology |
| Mares J, Hartung HP. (2020) Multiple sclerosis and COVID-19. Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia |
| Ghezzi A, Amato MP, Edan G, et al. (2020) The introduction of new medications in pediatric multiple sclerosis: Open issues and challenges. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520930620 |
| Graf J, Albrecht P, Goebels N, et al. (2020) [Ocrelizumab for treatment of multiple sclerosis]. Der Nervenarzt |
| Hartung HP. (2020) Ocrelizumab shorter infusion: Primary results from the ENSEMBLE PLUS substudy in patients with MS. Neurology(R) Neuroimmunology & Neuroinflammation. 7 |
| Bittner S, Steffen F, Uphaus T, et al. (2020) Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study. Ebiomedicine. 56: 102807 |
| Landmeyer NC, Bürkner PC, Wiendl H, et al. (2020) Disease-modifying treatments and cognition in relapsing-remitting multiple sclerosis: A meta-analysis. Neurology. 94: e2373-e2383 |